Advisor Group Holdings, Inc.
- SEC CIK
- 0001677044
- Latest filing
- Aug 14, 2026
GANX holding history
Gain Therapeutics, Inc. in every 13F filed by Advisor Group Holdings, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GANX overviewAll 13F holders of GANXFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,000
- Value
- $4.06K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,000 | $4.06K | <0.1% | +2,000 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −10,000−100.0% | Sold out | Holders |
| Q4 2023 | 10,000 | $32.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,000 | $32.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,000 | $44.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,000 | $48.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,000 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,000 | $33.0K | <0.1% | −100−1.0% | Reduced | Holders |
| Q2 2022 | 10,100 | $36.0K | <0.1% | +50+0.5% | Added | Holders |
| Q1 2022 | 10,050 | $41.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 10,050 | $54.0K | <0.1% | +10,050 | New | Holders |